very interesting
Transgene have linked up with Novartis
Novartis have paid $10m euro option fee to Transgene to purchase the worldwide rights to the lung cancer drug
arrangement includes milestone payments of up to $700m euro if all goes well.
transgene announcement, page-3
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)